Phase II trial of S-1 for elderly patients over 75 years with advanced gastric cancer as first-line treatment（OGSG0404）
国際学会発表
Phase III Trail of perioperative alone compared with perioperative plus postoperative antimicrobial prophylaxis in gastric cancer surgery (OGSG0501)
Randomized phase II trial of S-1 plus irinotecanversus S-1 plus paclitaxelas first-line treatment for advanced gastric cancer (OGSG0402)
Phase I/II study of weekly taxol plus irinotecan for patients with advanced of recurrent gastric cancer (OGSG0104)
A feasibility/phase II study of UFT/LV and irinotecan (TEGAFIRI) in advanced or metastatic colorectal cancer (CRC) (OGSG 0304)
Preventive effect of Carbamazepine for neurotoxicity of modified FOLFOX6 of metastatic colorectal cancer (mCRC): a prospective phase II study (OGSG 0603 study)
Phase II study of bi-weekly CPT-11+CDDP for patients with gastric cancer refractory to S-1 (OGSG 0504 study)
Multi-Center Phase II Study for Combination Therapy with Paclitaxel/Doxifluridine to Treat Advanced/Recurrent Gastric Cancer Showing Resistance to S-1 (OGSG0302)
Multi-center, phase II study for combination therapy with paclitaxel/doxifluridine to treat advanced/recurrent gastric cancer showing resistence to S-1: Final results (OGSG0302)
Muticenter Phase II Study of 2 Weeks Administration with TS-1 Followed by 1 Week Rest against Metastatic Gastric Cancer